Medical Bacteriology (Arizona State University)
Bacterial Pathogens MIC 379
Bacterial pathogenesis refers to the mechanisms by which bacteria cause disease in
humans. Understanding the pathogenicity of bacteria is essential for developing
strategies to prevent and treat bacterial infections.
Host-pathogen interaction: The initial step in bacterial pathogenesis is the interaction
between the bacteria and the host. The bacteria must adhere to and colonize a host
tissue in order to cause disease. This is often achieved through the use of adhesins,
which are bacterial surface proteins that bind to host cell receptors. Once the bacteria
have established a foothold, they can proliferate and produce virulence factors.
Bacterial virulence factors: Virulence factors are bacterial molecules that enable the
bacteria to cause disease. These factors include toxins, adhesins, capsules, and
enzymes. Toxins can cause tissue damage, while adhesins help the bacteria attach
to host tissues. Capsules are protective layers that can prevent the immune system
from recognizing the bacteria, and enzymes can break down host tissues or interfere
with the immune response.
Immune response to bacterial infections: The immune system plays a critical role in
the response to bacterial infections. Innate immune responses include the activation
of phagocytic cells, such as macrophages and neutrophils, which engulf and kill the
bacteria. Adaptive immune responses involve the production of antibodies that can
recognize and neutralize the bacteria. However, some bacteria have evolved
mechanisms to evade the immune response, such as the production of capsules or the
ability to invade host cells.
Diagnosis and treatment of bacterial infections: The diagnosis of bacterial infections
involves the use of laboratory tests to identify the causative agent, such as culturing
the bacteria or detecting bacterial DNA. Treatment of bacterial infections typically
involves the use of antibiotics, which target specific bacterial structures or
processes. However, the rise of antibiotic-resistant bacteria has led to the
development of alternative treatment strategies, such as the use of bacteriophages
or immunotherapies.